Intensive Palliative Care for Patients With Hematological Cancer Dying in Hospice: Analysis of the Level of Medical Care in the Final Week of Life

American Journal of Hospice and Palliative Medicine

Volumn 32, Issue 2, 2015, Pages 221-225

  Cheng, Benjamin Hon Wai ^a,b   Sham, Michael Mau Kwong ^a   Chan, Kwok Ying ^a   Li, Cho Wing ^a   Au, Ho Yan ^b  

^a GRANTHAM HOSPITAL   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

dying; hematology; hospice; intensive; oncology; palliative care

Indexed keywords

ANTIINFECTIVE AGENT; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; BLOOD EXAMINATION; BLOOD TRANSFUSION; FEMALE; HEMATOLOGIC NEOPLASMS; HONG KONG; HOSPICE CARE; HUMAN; MALE; MIDDLE AGED; PALLIATIVE THERAPY; PROCEDURES; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TERMINAL CARE; TOTAL PARENTERAL NUTRITION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BLOOD TRANSFUSION; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOLOGIC NEOPLASMS; HEMATOLOGIC TESTS; HONG KONG; HOSPICE CARE; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; PARENTERAL NUTRITION, TOTAL; RETROSPECTIVE STUDIES; TERMINAL CARE;

EID: 84922735479     PISSN: 10499091     EISSN: 19382715     Source Type: Journal    
DOI: 10.1177/1049909113512412     Document Type: Article

References (20)

1. Manitta VJ,Philip JA,Cole-Sinclair MF.Palliative care and the hemato-oncological patient: can we live together? a review of the literature.J Palliat Med. 2010;13 (8): 1021-1025
2. McGrath P.Qualitative findings on the experience of end-of-life care for haematological malignancies.Am J Hosp Palliat Care. 2002;19 (2): 103-111
3. Hunt RW,Fazekas BS,Luke CG,Priest KR,Roder DM.The coverage of cancer patients by designated palliative services: a population-based study, South Australia, 1999.Palliat Med. 2002;16 (5): 403-409
4. Bruera E,Russel N,Sweeney C,Fisch M,Palmer JL.Place of death and its predictors for local patients registered at a comprehensive cancer centre.J Clin Oncol. 2002;20 (8): 2127-2133
5. Cheng WW,Willey J,Palmer JL,Zhang T,Bruera E.Interval between palliative care referral and death among patients treated at a comprehensive cancer centre.J Palliat Med. 2005;8 (5): 1025-1032
6. Corbett CL,Johnstone M,Trauer JM,Spruyt O.Palliative care and hematological malignancies: increased referrals at a comprehensive cancer centre.J Palliat Med. 2013;16 (5): 537-541
7. McGrath P,Holewa H.Special considerations for haematology patients in relation to end-of-life care: Australian findings.Eur J Cancer Care. 2007;16 (2): 164-171
8. Bauder F,Capdupuy C,Renoux M.Characteristics of deaths in a department of oncohaematology from a general hospital: a study of 81 cases.Support Care Cancer. 2000;8 (4): 302-306
9. Strasser F,Blum D,Bueche D.Invasive palliative interventions: when are they worth it and when are they not?.Cancer J. 2010;16 (5): 483-487
10. Nosari A,Barberis M,Landonio G, et al.Infections in haematologic neoplasms: autopsy findings.Haematologica. 1991;76 (2): 135-140
11. Reinbolt RE,Shenk AM,White PH,Navari RM.Symptomatic treatment of infections in patients with advanced cancer receiving hospice care.J Pain Symptom Manage. 2005;30 (2): 175-182
12. White PH,Kuhlenschmidt HL,Vancura BG,Navari RM.Antimicrobial use in patients with advanced cancer receiving hospice care.J Pain Symptom Manage. 2003;25 (5): 438-443
13. Albrecht JS,McGregor JC,Fromme EK,Bearden DT,Furuno JP.A Nationwide analysis of antibiotic use in hospice care in the final week of life.J Pain Symptom Manage. 2013;46 (4): 483-490
14. Benjamin Cheng HW,Sham MK,Chan KY.Emergence of Vancomycin-Resistant Enterococci in the Palliative Care Setting—How to Strike the Right Balance in Infection Control Measures? J Pain Symptom Manage.:
15. Smith LB,Cooling L,Davenport R.How do I allocate blood products at the end of life? an ethical analysis with suggested guidelines.Transfusion. 2013;53 (4): 696-700
16. Fritz A,Percy C,Jack A, et alInternational Classification of Diseases for Oncology, 3 rd ed. Geneva, Switzerland: World Health Organization; 2000:
17. Doorduijn JK,Kluin-Nelemans HC.Management of mantle cell lymphoma in the elderly patient.Clin Interv Aging. 2013;8:1229-1236
18. Kluin-Nelemans HC,Hoster E,Hermine O, et al.Treatment of older patients with mantle cell lymphoma.N Engl J Med. 2012;367 (6): 520-531
19. Auret K,Bulsara C,Joske D.Australian haematologist referral patterns to palliative care: lack of consensus on when and why.Intern Med J. 2003;33 (12): 566-571
20. Brück P,Pierzchlewska M,Kaluzna-Oleksy M, et al.Dying of hematologic patients – Treatment characteristics in a German University Hospital.Support Care Cancer. 2012;20 (11): 2895-2902